Champions Oncology Inc (CSBR) Stock Increases 1.67% This Week; Should You Buy?

Wednesday, April 05, 2023 11:31 AM | InvestorsObserver Analysts

Mentioned in this article

Champions Oncology Inc (CSBR) Stock Increases 1.67% This Week; Should You Buy?

Champions Oncology Inc (CSBR) stock is lower by -48.86% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives CSBR stock a score of 0 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 0. CSBR's rank also includes a long-term technical score of 0.

CSBR has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on CSBR!

See Full CSBR Report

What's Happening with CSBR Stock Today

Champions Oncology Inc (CSBR) stock has gained 1.71% while the S&P 500 is lower by -0.53% as of 11:09 AM on Wednesday, Apr 5. CSBR is higher by $0.07 from the previous closing price of $4.18 on volume of 27,814 shares. Over the past year the S&P 500 is lower by -9.86% while CSBR is lower by -48.86%. CSBR lost -$0.23 per share in the over the last 12 months. Click Here to get the full Stock Report for Champions Oncology Inc stock.